Form 4 Filing for Biofrontera Inc.

Eugene Frederick Leffler, Chief Financial Officer of Biofrontera Inc., reported a transaction on July 28, 2026. Leffler acquired 31,250 shares of common stock through the settlement of restricted stock units. These restricted stock units were granted on July 22, 2025, with vesting in two equal annual installments starting July 22, 2026. Each vested unit is settled at the company's discretion in shares, cash, or a combination thereof. The acquisition resulted in Leffler directly owning 206,250 shares of Biofrontera Inc. common stock post-transaction. The filing also noted other restricted stock units with different terms were not included.